Joint (NASDAQ:JYNT – Get Free Report) and Addus HomeCare (NASDAQ:ADUS – Get Free Report) are both healthcare companies, but which is the superior business? We will compare the two businesses based on the strength of their risk, institutional ownership, dividends, valuation, earnings, profitability and analyst recommendations.
Analyst Ratings
This is a breakdown of current ratings for Joint and Addus HomeCare, as provided by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Joint | 1 | 2 | 0 | 0 | 1.67 |
| Addus HomeCare | 1 | 4 | 5 | 1 | 2.55 |
Addus HomeCare has a consensus price target of $129.33, suggesting a potential upside of 3.02%. Given Addus HomeCare’s stronger consensus rating and higher probable upside, analysts plainly believe Addus HomeCare is more favorable than Joint.
Insider and Institutional Ownership
76.9% of Joint shares are held by institutional investors. Comparatively, 95.3% of Addus HomeCare shares are held by institutional investors. 30.2% of Joint shares are held by insiders. Comparatively, 4.1% of Addus HomeCare shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.
Profitability
This table compares Joint and Addus HomeCare’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Joint | 6.49% | 12.02% | 3.47% |
| Addus HomeCare | 7.13% | 9.96% | 7.62% |
Risk and Volatility
Joint has a beta of 1.09, meaning that its share price is 9% more volatile than the S&P 500. Comparatively, Addus HomeCare has a beta of 0.83, meaning that its share price is 17% less volatile than the S&P 500.
Valuation & Earnings
This table compares Joint and Addus HomeCare”s gross revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Joint | $54.90 million | 1.81 | $2.91 million | $0.27 | 26.04 |
| Addus HomeCare | $1.42 billion | 1.65 | $95.91 million | $5.70 | 22.02 |
Addus HomeCare has higher revenue and earnings than Joint. Addus HomeCare is trading at a lower price-to-earnings ratio than Joint, indicating that it is currently the more affordable of the two stocks.
Summary
Addus HomeCare beats Joint on 10 of the 15 factors compared between the two stocks.
About Joint
The Joint Corp. operates and franchises chiropractic clinics in the United States. The company operates in two segments, Corporate Clinics and Franchise Operations. The Joint Corp. was incorporated in 2010 and is headquartered in Scottsdale, Arizona.
About Addus HomeCare
Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health. The Personal Care segment provides non-medical assistance with activities of daily living. This segment offers services that include assistance with bathing, grooming, oral care, feeding and dressing, medication reminders, meal planning and preparation, housekeeping, and transportation services. The Hospice segment provides palliative nursing care, social work, spiritual counseling, homemaker, and bereavement counseling services for people who are terminally ill, as well as related services for their families. The Home Health segment offers skilled nursing and physical, occupational, and speech therapy for the individuals who requires assistance during an illness or after hospitalization. The company's payor clients include federal, state, and local governmental agencies; managed care organizations; commercial insurers; and private individuals. Addus HomeCare Corporation was founded in 1979 and is headquartered in Frisco, Texas.
Receive News & Ratings for Joint Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Joint and related companies with MarketBeat.com's FREE daily email newsletter.
